- Home
- XBIO vs MRM Comparison
XBIO vs MRM Comparison
Compare XBIO & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- MRM
- Stock Information
- Founded
- XBIO N/A
- MRM 2000
- Country
- XBIO United States
- MRM Japan
- Employees
- XBIO N/A
- MRM N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- MRM Other Consumer Services
- Sector
- XBIO Health Care
- MRM Consumer Discretionary
- Exchange
- XBIO Nasdaq
- MRM Nasdaq
- Market Cap
- XBIO 5.8M
- MRM 5.9M
- IPO Year
- XBIO N/A
- MRM 2020
- Fundamental
- Price
- XBIO $2.72
- MRM $0.78
- Analyst Decision
- XBIO Hold
- MRM
- Analyst Count
- XBIO 1
- MRM 0
- Target Price
- XBIO N/A
- MRM N/A
- AVG Volume (30 Days)
- XBIO 9.9K
- MRM 4.0M
- Earning Date
- XBIO 05-08-2025
- MRM 01-01-0001
- Dividend Yield
- XBIO N/A
- MRM N/A
- EPS Growth
- XBIO N/A
- MRM N/A
- EPS
- XBIO N/A
- MRM N/A
- Revenue
- XBIO $2,500,284.00
- MRM $44,462,062.00
- Revenue This Year
- XBIO $14.23
- MRM N/A
- Revenue Next Year
- XBIO N/A
- MRM N/A
- P/E Ratio
- XBIO N/A
- MRM N/A
- Revenue Growth
- XBIO N/A
- MRM 2.80
- 52 Week Low
- XBIO $2.20
- MRM $0.34
- 52 Week High
- XBIO $5.20
- MRM $8.39
- Technical
- Relative Strength Index (RSI)
- XBIO 48.09
- MRM 52.70
- Support Level
- XBIO $2.32
- MRM $0.71
- Resistance Level
- XBIO $2.61
- MRM $0.90
- Average True Range (ATR)
- XBIO 0.15
- MRM 0.19
- MACD
- XBIO 0.07
- MRM 0.01
- Stochastic Oscillator
- XBIO 99.83
- MRM 42.61
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.